Laboratory Equipment |
Bigger Lungs Tied To Higher Success Rate Of Transplants: Could A Person’s …
Medical Daily “An unresolved question in the field of lung transplantation is how the size of the donor lungs relative to the recipient affects transplant success,” said Eberlain, who is a clinical assistant professor in internal medicine at the University of Iowa … Bigger Lungs May Be Better for TransplantsNewswise (press release) For Lung Transplant, Researchers Surprised to Learn Bigger Appears to Be BetterScience Daily (press release) Lung transplant patients may fare better with larger organs – using a …Big News Network.com Headlines & Global News all 7 news articles » |
Answers About Rheumatoid Arthritis, Part 3 – New York Times
Answers About Rheumatoid Arthritis, Part 3New York TimesThese include small molecules (pills) like methotrexate, leflunomide, tofacitinib and injectable or infusable biologic therapies like abatacept, adalimumab, certolizumab, etanercept, golimumab, ri…
Rituximab bei ANCA-Vaskulitis: Premiere einer Transparenz-Studie – Deutsches Ärzteblatt
|
Rituximab bei ANCA-Vaskulitis: Premiere einer Transparenz-Studie
Deutsches Ärzteblatt Boston – Eine randomisierte Studie in einer eher seltenen klinischen Indikation könnte nicht nur den Betroffenen mit ANCA-assoziierter Vaskulitis nutzen, für die eine Behandlung mit dem Antikörper Rituximab die bessere Wahl sein könnte. Die Studie im … |
Pat's Place: Risk Versus Reward When Considering A Stem Cell Transplant – The Myeloma Beacon
|
Pat’s Place: Risk Versus Reward When Considering A Stem Cell Transplant
The Myeloma Beacon In last month’s column, I wrote about how much my perspective on myeloma therapy has changed over the past six years since my diagnosis. In a nutshell, I’m more willing to try new things and endure troubling side effects now than I was back when I was … |
Promising compound could offer new treatment for heart failure – Science Codex
|
Promising compound could offer new treatment for heart failure
Science Codex Heart failure occurs when the heart cannot pump enough blood to meet the body’s needs. It’s a very common condition, affecting about six million people in the United States, but current therapies are not adequately effective at improving health and … New designer compound treats heart failure by targeting cell nucleusMedical Xpress |
Rituximab therapy effective for ANCA-associated vasculitis – Phys.Org
Rituximab therapy effective for ANCA-associated vasculitisPhys.OrgIn an article published today in the New England Journal of Medicine, Immune Tolerance Network (ITN) researchers demonstrated that a single course of rituximab therapy (anti-CD20; Rituxa…
New Heart Failure Guidelines — They Just Get Better – Medscape
MedscapeNew Heart Failure Guidelines — They Just Get BetterMedscapeIt is an exciting month for us because the new guidelines for heart failure from the joint work of the American College of Cardiology Foundation and the American Heart Association have…
Rituximab noninferior to conventional therapy in ANCA-associated vasculitis … – 2 Minute Medicine
Rituximab noninferior to conventional therapy in ANCA-associated vasculitis …2 Minute Medicine1. At 18 months, patients with ANCA-associated vasculitis treated with one course of rituximab had similar outcomes in terms of inducing remission when comp…
Home News Have you registered to become an organ donor?… – Caledon Enterprise
Home News Have you registered to become an organ donor?…Caledon EnterpriseCaledon resident Hattie Dunstan is alive today because someone signed their organ donor card. She underwent a double lung transplant three years ago and beat the odds stacked a…
Thailand's king leaves hospital after 4 years – Times of India
Times of India |
Thailand’s king leaves hospital after 4 years
Times of India King Bhumibol Adulyadej and Queen Sirikit traveled by car on Thursday to Klai Kangwon Palace in Hua Hin town, where they lived before the world’s longest-reigning monarch was hospitalized with lung inflammation in September 2009. Tens of thousands of … |